Home
Commodore Capital reported a 7.7% stake in Enliven Therapeutics ELVN · 4,800,940 sh · amendment · passive holder
Trade details
- Type
- 5% stake report
- Report
- 13G passive · amendment
- Stake
- 7.7%
- Last report
- 9.9% · filed 25/08/14
- Shares held
- 4,800,940 sh
- Class
- Common Stock, par value $0.001 per share
- Holder
- Commodore Capital
- Event date
- 26/03/31
- Filed
- 26/05/15
7.7% stake · −2.2pp from the last report
- Stake
- 7.7%
- Last report
- 9.9%
- Since last report
- −2.2pp
Enliven Therapeutics trades, last 26 weeks
What else happened in Enliven Therapeutics around then
Filed or reported within 30 days of the trade day · 03/01~04/30Commodore Capital's other 5% stake reports
- Commodore Capital
5% stakeJatt III Acquisition
5% stakeJatt III Acquisition
JTTT
5.2% stake
400,000 sh
5.2% stake
Filed 09/02
- Commodore Capital
5% stakeInflaRx
5% stakeInflaRx
IFRX
5.1% stake
7,475,000 sh
5.1% stake
Filed 08/17
- Commodore Capital
5% stakePalisade Bio
5% stakePalisade Bio
PALI
0% stake
0 sh
0% stake
Filed 08/14
- Commodore Capital
5% stakeJatt II Acquisition
5% stakeJatt II Acquisition
JATT
0% stake
0 sh
0% stake
Filed 08/14
- Commodore Capital
5% stakeRelay Therapeutics
5% stakeRelay Therapeutics
RLAY
5.5% stake
12,000,000 sh
5.5% stake
Filed 08/14
